Thrivent Financial for Lutherans’s NovoCure NVCR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
Sell
2024
Q4
$775K Sell
2024
Q3
$570K Hold
2024
Q2
$626K Buy
2019
Q4
Sell
2019
Q3
$3.54M Sell
2019
Q2
$5.62M Buy
2019
Q1
$4.23M Sell
2018
Q4
$4.71M Buy
2018
Q3
$6.26M Sell
2018
Q2
$4.19M Buy